Letter to the Editor Regarding 'Tafamidis 61 mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIA™ LRx)' No … ← Impact of a kidney-adjusted ERAS<sup>®</sup> protocol on postoperative outcomes in patients undergoing partial nephrectomy Sleep disturbances are associated with multiple definitions of long COVID →